AI is everywhere in healthcare, and May's big question is whether it's actually delivering. The money is flowing, the promises are bold, but some cracks are starting to show.

Steve and Michael break down the month's biggest stories.

We cover:

Digital health hitting its strongest funding quarter since the pandemic peak, and why deal concentration tells the real story
How Medvi built a billion-dollar GLP-1 company on fake doctor profiles, fake reviews, and a drug with zero bioavailability
Why AI in prior authorization and billing may be inflating healthcare costs rather than cutting them
The peptide craze: what the science says, what regulators have banned, and why Michael is actually taking one
How AI could collapse today's narrow medical specialties into a "generalist specialist" model
New research showing Epic's out-of-the-box AI models fall short on real-world clinical benchmarks